Promising diabetes drug offers new hope for prostate cancer treatment

Credit: Unsplash+.

Prostate cancer is a common and often treatable disease when it’s detected early.

However, for some patients, the cancer can spread to other parts of the body, making it much more difficult to treat and potentially life-threatening. This advanced stage of prostate cancer is known as metastatic prostate cancer.

In metastatic prostate cancer, the outlook is not as favorable as for those with localized cancer. Finding effective treatments for this stage of the disease has been a significant challenge for medical researchers.

A Breakthrough Discovery

Now, a group of researchers from MedUni Vienna, leading an international team, has made a breakthrough in understanding how prostate cancer spreads.

They’ve discovered a potential new way to treat it using a medication that’s commonly used to manage diabetes. Their findings were recently published in the journal Molecular Cancer.

The researchers conducted their study using a complex mouse model. They found a key player in the spread of prostate cancer: a protein called STAT3.

When another protein called interleukin 6 (IL6) activates STAT3, it can drive the progression of prostate cancer.

However, here’s the intriguing part: if we keep STAT3 active, it might actually delay the onset of prostate cancer and stop it from spreading to other parts of the body. This discovery could potentially revolutionize our approach to treating this aggressive cancer.

The Connection Between Diabetes and Prostate Cancer

During their research, the team also noticed something interesting. When STAT3 is active in the prostate, it increases the levels of certain components associated with glucose metabolism and type 2 diabetes.

These components, known as LKB1/pAMPK, can actually slow down tumor growth by interfering with specific cancer molecules (mTOR and CREB).

An Existing Diabetes Medication Shows Promise

Taking advantage of this discovery, the researchers decided to test an existing diabetes medication called metformin.

The results were promising. Metformin significantly slowed down the progression of STAT3-positive prostate cancer in their experiments.

This is significant because it suggests that a medication we already have on the market for diabetes might also be useful for treating certain types of prostate cancer.

Since metformin is already available and widely used, this finding could speed up the development of new treatments for patients with this aggressive form of cancer.

Prostate Cancer Prevalence and the Potential Impact of This Research

Prostate cancer is a significant health concern, and it’s particularly common in Austrian men, where it has been the leading cancer type since 1994.

While most prostate cancers are localized and can be treated successfully, about 20% of cases progress to the more dangerous metastatic stage. Globally, prostate cancer is the second-leading cause of cancer-related deaths in men.

The exciting aspect of this study is that it offers a potential solution to a problem that has long puzzled researchers: how to effectively treat metastatic prostate cancer.

By repurposing a common diabetes medication, we may be able to improve outcomes for patients with this aggressive form of cancer.

Further Research and Future Possibilities

While these findings are promising, more research is needed to confirm their validity and to determine the best ways to use metformin in treating prostate cancer. Clinical trials involving human patients will be necessary to move forward.

In the meantime, this research serves as a beacon of hope for prostate cancer patients, offering the possibility of a more effective and readily available treatment option.

For those interested in prostate cancer research, there are ongoing studies exploring the relationship between diet, specifically egg consumption, and prostate cancer.

Additionally, other research is focused on developing new strategies for treating advanced prostate cancer, including the use of combinations of drugs.

The study published in Molecular Cancer represents a significant step forward in our understanding of prostate cancer and offers hope for improved treatment options in the future.

If you care about cancer risk, please read studies that exercise may stop cancer in its tracks, and vitamin D can cut cancer death risk.

For more information about cancer, please see recent studies that yogurt and high-fiber diet may cut lung cancer risk, and results showing that new cancer treatment may reawaken the immune system.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.